Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17.222 USD | +8,32% | +10,97% | +14,82% |
2022 | Odonate Therapeutics krijgt Nasdaq bericht om aandelen van de beurs te halen | MT |
2021 | Insider verkoopt: Odonate Therapeutics | MT |
Omzet 2019 | - | Omzet 2020 | - | Marktkapitalisatie | 740 mln. 695 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -112 mln. -105 mln. | Nettowinst (verlies) 2020 | -126 mln. -118 mln. | EV/omzet 2019 | - |
Nettoliquiditeiten 2019 | 178 mln. 167 mln. | Nettoliquiditeiten 2020 | 152 mln. 143 mln. | EV/omzet 2020 | - |
K/w-verhouding 2019 * |
-
| K/w-verhouding 2020 |
-
| Werknemers | 145 |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 100% |
1 dag | +8,32% | ||
1 week | +10,97% | ||
Lopende maand | -1,59% | ||
1 maand | +2,12% | ||
3 maanden | +20,86% | ||
6 maanden | +14,82% | ||
Lopend jaar | +14,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | 01-01-13 |
Michael Hearne
DFI | Director of Finance/CFO | 61 | 01-01-15 |
Ryan Cole
COO | Chief Operating Officer | - | 01-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | 01-01-13 |
Craig Johnson
BRD | Director/Board Member | 62 | 01-07-17 |
Aaron Davis
BRD | Director/Board Member | 45 | 01-12-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 17.222 | +8,32% | 1 |
16-04-24 | 15.900 | +2,45% | 9 |
11-04-24 | 15.520 | +0,45% | 11 |
uitgestelde koers OTC Markets, 19 april 2024 om 21:24 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+14,82% | 48,91 mln. | |
+24,60% | 654 mld. | |
+24,08% | 552 mld. | |
-5,63% | 356 mld. | |
+15,37% | 319 mld. | |
+7,38% | 295 mld. | |
+3,26% | 211 mld. | |
+0,78% | 206 mld. | |
-9,69% | 147 mld. | |
-6,63% | 144 mld. |